US Newborn Screening Market is Poised for an Impressive Growth!

2026-08-17 02:04:11 Business

591

According to a new research report by RNCOS entitled, ?US Newborn Screening Market Outlook 2020?, The US newborn screening market size has been studied by revenue generated by the number of tests performed and screening technologies separately during 2014. It has been observed that neonatal screening accounts to have 93% penetration in the country provided that approximately 4 million infants are screened each year for several genetic conditions. The five most commonly diagnosed conditions in the United States are i) hearing loss, ii) primary congenital hypothyroidism, iii) cystic fibrosis, iv) sickle cell disease, and v) medium-chain acyl-CoA dehydrogenase deficiency. The conditions on the uniform newborn screening panel, except hearing loss and critical congenital heart disease, are detected by dried blood spot screening. The average cost of the newborn blood spot screening system in 51 states of the US is approximately US$80.

Based on the RNCOS analysis about the number of babies screened in 2014 and cost of the tests, the market for newborn screening test was valued at US$ 264 Million. Growing penetration of genetic disorders, promotion of mandatory screening program by federal government, high awareness of expectant mothers are major contributors to the growth of these tests over the years. In addition to the aforementioned factors, estimated increase in penetration of screening procedures from 93% in 2014 to 95% by 2020, the market is set to rise with 3% CAGR in next six years.

The US newborn screening technology market represented 45% of the global newborn screening market in 2014 and has been forecasted to expand at 5.1% CAGR from 2014-2020. Newborn screening technologies including those of tandem mass spectrometry, Next Generation Sequencing, Immunoassays etc., have greatly increased the ability to detect potential disease in asymptomatic newborns.

Research Analysis and Highlights

The report is spreaded across 38 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Newborn Screening market in the US. The report provides a clear picture of the factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes industry developments that have occurred during past two years. The report further highlights market segmentation of the industry by types of screening technologies. With special emphasis on competitive landscape and dominant players in the market, the research provides valuable information to the investors who are looking to enter in this market.

Some of the key highlights of the report include the following:

? Newborn Screening Test Recommended for Pompe?s Disease
? Next Generation Sequencing Foraying into Newborn Screening
? Unclear Regulatory Policies Challenging the Market Growth

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM819.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.